ZaroffS, and TanG: Hybridoma technology: The preferred method for monoclonal antibody generation for in vivo applications. Biotechniques, 2019; 67:90–92.
3.
DreweE, and PowellRJ: Clinically useful monoclonal antibodies in treatment. Journal of clinical pathology, 2002; 55:81–85.
4.
LuR-M, HwangY-C, LiuIJ, LeeC-C, TsaiH-Z, LiH-J, and WuH-C: Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci, 2020; 27:1.
5.
JerneNK: Towards a network theory of the immune system. Ann Immunol (Paris), 1974; 125c:373–389.
6.
GaleottiC, KaveriSV, and BayryJ: Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19). Clin Transl Immunology, 2020; 9:e1198.
7.
MaddurMS, Lacroix-DesmazesS, DimitrovJD, KazatchkineMD, BayryJ, and KaveriSV: Natural antibodies: from first-line defense against pathogens to perpetual immune homeostasis. Clin Rev Allergy Immunol, 2020; 58:213–228.
